Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Patterson Companies Inc is a medical distribution business based in the US. Patterson Companies shares (PDCO) are listed on the NASDAQ and all prices are listed in US Dollars. Patterson Companies employs 7,800 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$32.17|
|52-week range||$23.72 - $37.05|
|50-day moving average||$31.38|
|200-day moving average||$32.03|
|Wall St. target price||$34.55|
|Dividend yield||$1.04 (3.21%)|
|Earnings per share (TTM)||$1.71|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-1.68%|
|1 month (2021-09-17)||3.84%|
|3 months (2021-07-17)||5.58%|
|6 months (2021-04-16)||-0.43%|
|1 year (2020-10-16)||17.11%|
|2 years (2019-10-17)||84.04%|
|3 years (2018-10-17)||31.47%|
|5 years (2016-10-17)||44.09|
Valuing Patterson Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Patterson Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Patterson Companies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Patterson Companies shares trade at around 19x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Patterson Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0984. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Patterson Companies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Patterson Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $299.6 million.
The EBITDA is a measure of a Patterson Companies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$6.3 billion|
|Operating margin TTM||3.5%|
|Gross profit TTM||$1.2 billion|
|Return on assets TTM||5.1%|
|Return on equity TTM||17.95%|
|Market capitalisation||$3.1 billion|
TTM: trailing 12 months
There are currently 5.6 million Patterson Companies shares held short by investors – that's known as Patterson Companies's "short interest". This figure is 5.5% down from 5.9 million last month.
There are a few different ways that this level of interest in shorting Patterson Companies shares can be evaluated.
Patterson Companies's "short interest ratio" (SIR) is the quantity of Patterson Companies shares currently shorted divided by the average quantity of Patterson Companies shares traded daily (recently around 874164.67817896). Patterson Companies's SIR currently stands at 6.37. In other words for every 100,000 Patterson Companies shares traded daily on the market, roughly 6370 shares are currently held short.
However Patterson Companies's short interest can also be evaluated against the total number of Patterson Companies shares, or, against the total number of tradable Patterson Companies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Patterson Companies's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Patterson Companies shares in existence, roughly 60 shares are currently held short) or 0.0644% of the tradable shares (for every 100,000 tradable Patterson Companies shares, roughly 64 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Patterson Companies.
Find out more about how you can short Patterson Companies stock.
Dividend payout ratio: 51.49% of net profits
Recently Patterson Companies has paid out, on average, around 51.49% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Patterson Companies shareholders could enjoy a 3.23% return on their shares, in the form of dividend payments. In Patterson Companies's case, that would currently equate to about $1.04 per share.
Patterson Companies's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Patterson Companies's most recent dividend payout was on 4 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 20 October 2021 (the "ex-dividend date").
Patterson Companies's shares were split on a 2:1 basis on 24 October 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Patterson Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Patterson Companies shares which in turn could have impacted Patterson Companies's share price.
Over the last 12 months, Patterson Companies's shares have ranged in value from as little as $23.7229 up to $37.0513. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Patterson Companies's is 1.5238. This would suggest that Patterson Companies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through three segments; Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.